High Dissatisfaction among Patients with Atopic Dermatitis: Opportunity for New Market Entrants

/

Atopic dermatitis, also known as eczema, appears most commonly in one-year old children, and about half of these children will have them when they become adults. Sadly, research reveals a very high dissatisfaction among adult patients of the treatments available for atopic dermatitis (AD). On the other hand, this is a good news for new entrants in the market.

The research done by GfK Disease Atlas on atopic dermatitis covered eight countries, over 4,000 pediatric and adult atopic dermatitis patients, and over 800 physicians. Results reveal that 6 out of 10 patients experiencing moderate to severe atopic dermatitis who were treated with topical steroids are not satisfied with the results.

This is amidst the the fact that about 92% of them said that their doctors explained what is expected from the treatment. Four out of 10 of doctors also expressed their dissatisfaction. Topical steroids are used mainly to reduce the swelling and inflammation in affected areas and control eczema.

There is a lack of options available for patients, making them repeat the same treatment options.This is the reason why GfK Immunology and Dermatology Therapy Director Alison Rose said that there is a huge potential for new players to enter the market and provide with other therapy options.

According to the American Academy of Dermatology, atopic dermatitis cannot be cured but it can be controlled. This is done by preventing AD from getting worse, calming the skin and relieving pain and itch, preventing infections, and stopping the skin from thickening.

Further, according to the AAD website, there is no way to determine if AD will ever go away or it will be a lifelong disease, however, it gets milder with age. Treatments, therefore, are very much important in preventing AD from getting worse and relieving a patient's discomfort.

Read more on: http://www.gfk.com/news-and-events/press-room/press-releases/pages/dissatisfaction-in-atopic-dermatitis-treatment.aspx https://www.aad.org/dermatology-a-to-z/diseases-and-treatments/a---d/atopic-dermatitis

Sun Protection

/
“But I love the sun!” ….is a phrase I hear in my office all too often - especially this time of year. My usual reply: “well, the sun doesn’t love you…” Skin cancer rates are on the rise. During the recent past, doctors have become increasingly aware of the increase in the rates of skin cancer in the United States, and have stressed the importance of the need for protection from ultraviolet (UV) radiation. The harm caused by UV includes premature aging (such as wrinkling and age spots), skin cancer, and permanent, sometimes blinding, damage to eyes. Doctors everywhere agree that education is critical to stopping the epidemic of sun related diseases - especially skin cancer. As to the actual physiological effects of UV radiation on the skin, I’ll spare the scintillating details. Suffice it to say that the sun ages our skin undoubtedly more than any other environmental factor. So, just in time for the summer, let’s come with and implement a sun safety program.
Read More

Dr. Sabine Zenker: Aesthetic Dermatologist In Munich, Germany

/

Dr. Sabine Zenker welcomes us to her clinic in Munich, Germany and she shares her thoughts on cosmetic dermatology, technology, and the operations of her clinic.Dr. Sabine Zenker Munich Board Certified Dermaologist

Dr. Sabine Zenker is a well know European dermatologist who has a passion for clinical research and teaching that we've been wanting to interview for some time. We finally got together to learn what this German dermatologist thinks. 

Name: Sabine Zenker, MD
Clinic: Dr. Zenker Dermatology
Location: Munich, Germany
Website: dr-zenker.de

That's interesting: Dr. Sabine Zenker is the consultant dermatologist for L'Oreal Paris and an internationally recognized authority on micro-invasive techniques. She is well known for her clinical research into both established and innovative technologies and treatments, teaching, training, and continuing professional development both in Germany and internationally.

She contributes regularly to medical journals, public press, print, TV and multimedia. Sabine Zenker is a member of a large number of national and international societies including DDG, AAD, ASCDAS, AAAACS, EADV, ISDS, DASIL etc. She serves as executive board member of ESCAD. She is also a speaker and clinical trainer on almost any recognized national and international congress in the aesthetic medical field

Read More